Core Laboratories CLB Restricted Shares Withheld From Employees For Settlement Of Tax Liabilities

Restricted Shares Withheld From Employees For Settlement Of Tax Liabilities at other companies

Kohl'sKSS

$6M+50.0%

Protagonist TherapeuticsPTGX

$479K-20.2%

SMB

SmartFinancialSMBK

$311K+17.4%

Grid Dynamics Holdings, Inc.GDYN

-$3.99M+75.4%

Allient Inc.ALNT

$18K-71.4%

Banc of CaliforniaBANC

$5.57M+107%

Other financials

Income statement

See full

Revenue$121.8M-1.4%

Operating income$1.9M-57.3%

Net income-$789.0K-412%

EPS (diluted)-$0.02—

Balance sheet

See full

Cash & equivalents$22.8M+3.2%

Total debt$167.8M-6.8%

Total equity$268.9M+6.1%

Total assets$587.7M+0.3%

Cash flow

See full

Operating cash flow$4.0M-40.5%

CapEx$3.4M+23.8%

Free cash flow$517.0K-86.7%

Valuation

See full

Market cap$503.38M-13.5%

Enterprise value$648.4M-12.3%

P/E17.3×-3.4×

P/S1×-0.2×

Profitability

See full

Operating margin10.3%-0.2pp

Net margin5.5%+0.1pp

FCF margin4.3%-4.6pp

Returns & leverage

See full

Return on equity11.1%-0.4pp

Debt / equity0.6×-0.1×

Current ratio2×-0.2×

Where this comes from

Reported directly by Core Laboratories in its filing.

Tagged under the XBRL concept clb:RestrictedSharesWithheldFromEmployeesForSettlementOfTaxLiabilities.

The official record: Core Laboratories’s 10-K, filed March 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Laboratories's restricted shares withheld from employees for settlement of tax liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Core Laboratories's restricted shares withheld from employees for settlement of tax liabilities?: Core Laboratories (CLB) reported restricted shares withheld from employees for settlement of tax liabilities of $765.25K in Q4 2025.
What does restricted shares withheld from employees for settlement of tax liabilities mean?: Represents the value of equity shares withheld by the company to satisfy employee tax withholding obligations upon the vesting of restricted stock. This provides insight into the cash impact of equity-based compensation programs on the company's liquidity.